Avacta > Pfizer15 Nov 2020 20:09
The Telegraph today:
One former director at pharmaceutical giant GSK told The Telegraph he was "utterly appalled" that Pfizer had released the clinical trial data before peer-review.
"Really it's just a cynical and egregious marketing ploy by Pfizer to get early orders, with money up front, because they know that mass vaccination with a vaccine that needs storage at -80 degrees is completely unworkable," he said. "It's just a dreadful example of big pharma trying to get its share price up and profits into its organisation before the Pfizer vaccine is declared totally impractical for widespread use in society.
"As soon as other vaccines are available, then this Pfizer vaccine will not be widely used. Hence their announcement to get in early." From telegraph news.
Maybe this explains why the CEO sold his 62% stake so quickly. The vaccine hype optimism being brought back to Earth! He should really be in prison!!
Let’s not moan too much though Avacta is now cheap as chips. Massively undervalued...